Transcatheter Arterial Chemoembolization with or without Radiofrequency Ablation in the Management of Patients with Advanced Hepatic Malignancy
Transcatheter arterial chemoembolization (TACE) is efficacious against hepatic malignancies by rendering tumors ischemic while delivering high-dose chemotherapy. The added benefit of radiofrequency ablation (RFA) has not been determined. We sought to review our experience with TACE with or without R...
Gespeichert in:
| Veröffentlicht in: | The American surgeon 2002-09, Vol.68 (9), p.827-831 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 831 |
|---|---|
| container_issue | 9 |
| container_start_page | 827 |
| container_title | The American surgeon |
| container_volume | 68 |
| creator | Bloomston, Mark Binitie, Odion Fraiji, Elie Murr, Michel Zervos, Emmanuel Goldin, Steven Kudryk, Bruce Zwiebel, Bruce Black, Thomas Fargher, Scott Rosemurgy, Alexander S. |
| description | Transcatheter arterial chemoembolization (TACE) is efficacious against hepatic malignancies by rendering tumors ischemic while delivering high-dose chemotherapy. The added benefit of radiofrequency ablation (RFA) has not been determined. We sought to review our experience with TACE with or without RFA in the treatment of hepatocellular carcinoma and colorectal liver metastases in patients not amenable to resection. TACE and RFA were undertaken in 13 patients with hepatocellular carcinoma (n = 7) or colorectal liver metastases (n = 6). Concurrently 24 patients underwent TACE alone for hepatocellular carcinoma (n = 15) or colorectal liver metastases (n = 9). Patients undergoing TACE with or without RFA were similar in age, gender, and diagnosis. Overall follow-up was 9.1 months ± 7.1. One-year survival was greater in patients undergoing TACE with RFA than with TACE alone (100% vs 67%, P = 0.04). Mean survival was longer after TACE with RFA compared with TACE alone (25.3 months ± 15.9 vs 11.4 months ± 7.3, P < 0.05). No patients suffered significant complications. The addition of RFA to TACE improves survival in patients with unresectable primary or metastatic hepatic malignancies. RFA with TACE should be in the armamentarium of surgeons caring for patients with malignant liver lesions. |
| doi_str_mv | 10.1177/000313480206800920 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_72141464</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sage_id>10.1177_000313480206800920</sage_id><sourcerecordid>72141464</sourcerecordid><originalsourceid>FETCH-LOGICAL-c396t-85ae5ebb8ae62d8400845522ad073bf6fc277618ba4c75b05d4deec523e0e8203</originalsourceid><addsrcrecordid>eNp9kc-KFDEQxoMo7rj6Ah4kCHprN_87cxwGdYUVRdZzk05X72TpTsakWxlfwle2xh4YUPCSSlK_-qqSj5DnnL3hvK6vGGOSS2WZYMYythbsAVlxrXW1tkI-JKsjUB2JC_KklHs8KqP5Y3LBhdSGG7Yiv26zi8W7aQcTZLrJuAY30O0OxgRjm4bw000hRfojTDua8p-Y5ol-cV1IfYZvM0R_oJt2WLgQKYrRjy66OxghTjT19DPmcFsWlU333UUPHb2GPSY8wkO4i3h3eEoe9W4o8OwUL8nXd29vt9fVzaf3H7abm8rLtZkqqx1oaFvrwIjOKsas0loI17Fatr3pvahrw23rlK91y3SnOgCvhQQGVjB5SV4vuvuc8AVlasZQPAyDi5Dm0tSCK66MQvDlX-B9mnPE2RrBhT32FQiJBfI5lZKhb_Y5jC4fGs6ao1fNv15h0YuT8tyO0J1LTuYg8OoEOHRo6NEpH8qZk2uOQ1rkrhau4I-fx_tP69_ptqrd</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>212808452</pqid></control><display><type>article</type><title>Transcatheter Arterial Chemoembolization with or without Radiofrequency Ablation in the Management of Patients with Advanced Hepatic Malignancy</title><source>MEDLINE</source><source>SAGE Complete A-Z List</source><creator>Bloomston, Mark ; Binitie, Odion ; Fraiji, Elie ; Murr, Michel ; Zervos, Emmanuel ; Goldin, Steven ; Kudryk, Bruce ; Zwiebel, Bruce ; Black, Thomas ; Fargher, Scott ; Rosemurgy, Alexander S.</creator><creatorcontrib>Bloomston, Mark ; Binitie, Odion ; Fraiji, Elie ; Murr, Michel ; Zervos, Emmanuel ; Goldin, Steven ; Kudryk, Bruce ; Zwiebel, Bruce ; Black, Thomas ; Fargher, Scott ; Rosemurgy, Alexander S.</creatorcontrib><description>Transcatheter arterial chemoembolization (TACE) is efficacious against hepatic malignancies by rendering tumors ischemic while delivering high-dose chemotherapy. The added benefit of radiofrequency ablation (RFA) has not been determined. We sought to review our experience with TACE with or without RFA in the treatment of hepatocellular carcinoma and colorectal liver metastases in patients not amenable to resection. TACE and RFA were undertaken in 13 patients with hepatocellular carcinoma (n = 7) or colorectal liver metastases (n = 6). Concurrently 24 patients underwent TACE alone for hepatocellular carcinoma (n = 15) or colorectal liver metastases (n = 9). Patients undergoing TACE with or without RFA were similar in age, gender, and diagnosis. Overall follow-up was 9.1 months ± 7.1. One-year survival was greater in patients undergoing TACE with RFA than with TACE alone (100% vs 67%, P = 0.04). Mean survival was longer after TACE with RFA compared with TACE alone (25.3 months ± 15.9 vs 11.4 months ± 7.3, P < 0.05). No patients suffered significant complications. The addition of RFA to TACE improves survival in patients with unresectable primary or metastatic hepatic malignancies. RFA with TACE should be in the armamentarium of surgeons caring for patients with malignant liver lesions.</description><identifier>ISSN: 0003-1348</identifier><identifier>EISSN: 1555-9823</identifier><identifier>DOI: 10.1177/000313480206800920</identifier><identifier>PMID: 12356160</identifier><identifier>CODEN: AMSUAW</identifier><language>eng</language><publisher>Los Angeles, CA: SAGE Publications</publisher><subject>Biological and medical sciences ; Blood vessels ; Carcinoma, Hepatocellular - mortality ; Carcinoma, Hepatocellular - therapy ; Catheter Ablation - methods ; Catheters ; Chemoembolization, Therapeutic - methods ; Chemotherapy ; Colorectal Neoplasms - pathology ; Combined Modality Therapy ; Female ; Gastroenterology. Liver. Pancreas. Abdomen ; Hepatitis ; Humans ; Liver Neoplasms - mortality ; Liver Neoplasms - secondary ; Liver Neoplasms - therapy ; Liver, biliary tract, pancreas, portal circulation, spleen ; Liver. Biliary tract. Portal circulation. Exocrine pancreas ; Male ; Medical sciences ; Middle Aged ; Retrospective Studies ; Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases ; Surgery of the digestive system ; Survival Rate ; Tumors</subject><ispartof>The American surgeon, 2002-09, Vol.68 (9), p.827-831</ispartof><rights>2002 Southeastern Surgical Congress</rights><rights>2002 INIST-CNRS</rights><rights>Copyright The Southeastern Surgical Congress Sep 2002</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c396t-85ae5ebb8ae62d8400845522ad073bf6fc277618ba4c75b05d4deec523e0e8203</citedby><cites>FETCH-LOGICAL-c396t-85ae5ebb8ae62d8400845522ad073bf6fc277618ba4c75b05d4deec523e0e8203</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://journals.sagepub.com/doi/pdf/10.1177/000313480206800920$$EPDF$$P50$$Gsage$$H</linktopdf><linktohtml>$$Uhttps://journals.sagepub.com/doi/10.1177/000313480206800920$$EHTML$$P50$$Gsage$$H</linktohtml><link.rule.ids>309,310,314,776,780,785,786,21799,23910,23911,25119,27903,27904,43600,43601</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=13911418$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12356160$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bloomston, Mark</creatorcontrib><creatorcontrib>Binitie, Odion</creatorcontrib><creatorcontrib>Fraiji, Elie</creatorcontrib><creatorcontrib>Murr, Michel</creatorcontrib><creatorcontrib>Zervos, Emmanuel</creatorcontrib><creatorcontrib>Goldin, Steven</creatorcontrib><creatorcontrib>Kudryk, Bruce</creatorcontrib><creatorcontrib>Zwiebel, Bruce</creatorcontrib><creatorcontrib>Black, Thomas</creatorcontrib><creatorcontrib>Fargher, Scott</creatorcontrib><creatorcontrib>Rosemurgy, Alexander S.</creatorcontrib><title>Transcatheter Arterial Chemoembolization with or without Radiofrequency Ablation in the Management of Patients with Advanced Hepatic Malignancy</title><title>The American surgeon</title><addtitle>Am Surg</addtitle><description>Transcatheter arterial chemoembolization (TACE) is efficacious against hepatic malignancies by rendering tumors ischemic while delivering high-dose chemotherapy. The added benefit of radiofrequency ablation (RFA) has not been determined. We sought to review our experience with TACE with or without RFA in the treatment of hepatocellular carcinoma and colorectal liver metastases in patients not amenable to resection. TACE and RFA were undertaken in 13 patients with hepatocellular carcinoma (n = 7) or colorectal liver metastases (n = 6). Concurrently 24 patients underwent TACE alone for hepatocellular carcinoma (n = 15) or colorectal liver metastases (n = 9). Patients undergoing TACE with or without RFA were similar in age, gender, and diagnosis. Overall follow-up was 9.1 months ± 7.1. One-year survival was greater in patients undergoing TACE with RFA than with TACE alone (100% vs 67%, P = 0.04). Mean survival was longer after TACE with RFA compared with TACE alone (25.3 months ± 15.9 vs 11.4 months ± 7.3, P < 0.05). No patients suffered significant complications. The addition of RFA to TACE improves survival in patients with unresectable primary or metastatic hepatic malignancies. RFA with TACE should be in the armamentarium of surgeons caring for patients with malignant liver lesions.</description><subject>Biological and medical sciences</subject><subject>Blood vessels</subject><subject>Carcinoma, Hepatocellular - mortality</subject><subject>Carcinoma, Hepatocellular - therapy</subject><subject>Catheter Ablation - methods</subject><subject>Catheters</subject><subject>Chemoembolization, Therapeutic - methods</subject><subject>Chemotherapy</subject><subject>Colorectal Neoplasms - pathology</subject><subject>Combined Modality Therapy</subject><subject>Female</subject><subject>Gastroenterology. Liver. Pancreas. Abdomen</subject><subject>Hepatitis</subject><subject>Humans</subject><subject>Liver Neoplasms - mortality</subject><subject>Liver Neoplasms - secondary</subject><subject>Liver Neoplasms - therapy</subject><subject>Liver, biliary tract, pancreas, portal circulation, spleen</subject><subject>Liver. Biliary tract. Portal circulation. Exocrine pancreas</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Retrospective Studies</subject><subject>Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases</subject><subject>Surgery of the digestive system</subject><subject>Survival Rate</subject><subject>Tumors</subject><issn>0003-1348</issn><issn>1555-9823</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNp9kc-KFDEQxoMo7rj6Ah4kCHprN_87cxwGdYUVRdZzk05X72TpTsakWxlfwle2xh4YUPCSSlK_-qqSj5DnnL3hvK6vGGOSS2WZYMYythbsAVlxrXW1tkI-JKsjUB2JC_KklHs8KqP5Y3LBhdSGG7Yiv26zi8W7aQcTZLrJuAY30O0OxgRjm4bw000hRfojTDua8p-Y5ol-cV1IfYZvM0R_oJt2WLgQKYrRjy66OxghTjT19DPmcFsWlU333UUPHb2GPSY8wkO4i3h3eEoe9W4o8OwUL8nXd29vt9fVzaf3H7abm8rLtZkqqx1oaFvrwIjOKsas0loI17Fatr3pvahrw23rlK91y3SnOgCvhQQGVjB5SV4vuvuc8AVlasZQPAyDi5Dm0tSCK66MQvDlX-B9mnPE2RrBhT32FQiJBfI5lZKhb_Y5jC4fGs6ao1fNv15h0YuT8tyO0J1LTuYg8OoEOHRo6NEpH8qZk2uOQ1rkrhau4I-fx_tP69_ptqrd</recordid><startdate>20020901</startdate><enddate>20020901</enddate><creator>Bloomston, Mark</creator><creator>Binitie, Odion</creator><creator>Fraiji, Elie</creator><creator>Murr, Michel</creator><creator>Zervos, Emmanuel</creator><creator>Goldin, Steven</creator><creator>Kudryk, Bruce</creator><creator>Zwiebel, Bruce</creator><creator>Black, Thomas</creator><creator>Fargher, Scott</creator><creator>Rosemurgy, Alexander S.</creator><general>SAGE Publications</general><general>Southeastern Surgical Congress</general><general>SAGE PUBLICATIONS, INC</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>4T-</scope><scope>4U-</scope><scope>7QL</scope><scope>7RV</scope><scope>7T7</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88I</scope><scope>8AF</scope><scope>8AO</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>M0R</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>M2P</scope><scope>M7N</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>S0X</scope><scope>7X8</scope></search><sort><creationdate>20020901</creationdate><title>Transcatheter Arterial Chemoembolization with or without Radiofrequency Ablation in the Management of Patients with Advanced Hepatic Malignancy</title><author>Bloomston, Mark ; Binitie, Odion ; Fraiji, Elie ; Murr, Michel ; Zervos, Emmanuel ; Goldin, Steven ; Kudryk, Bruce ; Zwiebel, Bruce ; Black, Thomas ; Fargher, Scott ; Rosemurgy, Alexander S.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c396t-85ae5ebb8ae62d8400845522ad073bf6fc277618ba4c75b05d4deec523e0e8203</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>Biological and medical sciences</topic><topic>Blood vessels</topic><topic>Carcinoma, Hepatocellular - mortality</topic><topic>Carcinoma, Hepatocellular - therapy</topic><topic>Catheter Ablation - methods</topic><topic>Catheters</topic><topic>Chemoembolization, Therapeutic - methods</topic><topic>Chemotherapy</topic><topic>Colorectal Neoplasms - pathology</topic><topic>Combined Modality Therapy</topic><topic>Female</topic><topic>Gastroenterology. Liver. Pancreas. Abdomen</topic><topic>Hepatitis</topic><topic>Humans</topic><topic>Liver Neoplasms - mortality</topic><topic>Liver Neoplasms - secondary</topic><topic>Liver Neoplasms - therapy</topic><topic>Liver, biliary tract, pancreas, portal circulation, spleen</topic><topic>Liver. Biliary tract. Portal circulation. Exocrine pancreas</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Retrospective Studies</topic><topic>Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases</topic><topic>Surgery of the digestive system</topic><topic>Survival Rate</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bloomston, Mark</creatorcontrib><creatorcontrib>Binitie, Odion</creatorcontrib><creatorcontrib>Fraiji, Elie</creatorcontrib><creatorcontrib>Murr, Michel</creatorcontrib><creatorcontrib>Zervos, Emmanuel</creatorcontrib><creatorcontrib>Goldin, Steven</creatorcontrib><creatorcontrib>Kudryk, Bruce</creatorcontrib><creatorcontrib>Zwiebel, Bruce</creatorcontrib><creatorcontrib>Black, Thomas</creatorcontrib><creatorcontrib>Fargher, Scott</creatorcontrib><creatorcontrib>Rosemurgy, Alexander S.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Docstoc</collection><collection>University Readers</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Nursing & Allied Health Database</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Virology and AIDS Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Consumer Health Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Science Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>SIRS Editorial</collection><collection>MEDLINE - Academic</collection><jtitle>The American surgeon</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bloomston, Mark</au><au>Binitie, Odion</au><au>Fraiji, Elie</au><au>Murr, Michel</au><au>Zervos, Emmanuel</au><au>Goldin, Steven</au><au>Kudryk, Bruce</au><au>Zwiebel, Bruce</au><au>Black, Thomas</au><au>Fargher, Scott</au><au>Rosemurgy, Alexander S.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Transcatheter Arterial Chemoembolization with or without Radiofrequency Ablation in the Management of Patients with Advanced Hepatic Malignancy</atitle><jtitle>The American surgeon</jtitle><addtitle>Am Surg</addtitle><date>2002-09-01</date><risdate>2002</risdate><volume>68</volume><issue>9</issue><spage>827</spage><epage>831</epage><pages>827-831</pages><issn>0003-1348</issn><eissn>1555-9823</eissn><coden>AMSUAW</coden><abstract>Transcatheter arterial chemoembolization (TACE) is efficacious against hepatic malignancies by rendering tumors ischemic while delivering high-dose chemotherapy. The added benefit of radiofrequency ablation (RFA) has not been determined. We sought to review our experience with TACE with or without RFA in the treatment of hepatocellular carcinoma and colorectal liver metastases in patients not amenable to resection. TACE and RFA were undertaken in 13 patients with hepatocellular carcinoma (n = 7) or colorectal liver metastases (n = 6). Concurrently 24 patients underwent TACE alone for hepatocellular carcinoma (n = 15) or colorectal liver metastases (n = 9). Patients undergoing TACE with or without RFA were similar in age, gender, and diagnosis. Overall follow-up was 9.1 months ± 7.1. One-year survival was greater in patients undergoing TACE with RFA than with TACE alone (100% vs 67%, P = 0.04). Mean survival was longer after TACE with RFA compared with TACE alone (25.3 months ± 15.9 vs 11.4 months ± 7.3, P < 0.05). No patients suffered significant complications. The addition of RFA to TACE improves survival in patients with unresectable primary or metastatic hepatic malignancies. RFA with TACE should be in the armamentarium of surgeons caring for patients with malignant liver lesions.</abstract><cop>Los Angeles, CA</cop><pub>SAGE Publications</pub><pmid>12356160</pmid><doi>10.1177/000313480206800920</doi><tpages>5</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0003-1348 |
| ispartof | The American surgeon, 2002-09, Vol.68 (9), p.827-831 |
| issn | 0003-1348 1555-9823 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_72141464 |
| source | MEDLINE; SAGE Complete A-Z List |
| subjects | Biological and medical sciences Blood vessels Carcinoma, Hepatocellular - mortality Carcinoma, Hepatocellular - therapy Catheter Ablation - methods Catheters Chemoembolization, Therapeutic - methods Chemotherapy Colorectal Neoplasms - pathology Combined Modality Therapy Female Gastroenterology. Liver. Pancreas. Abdomen Hepatitis Humans Liver Neoplasms - mortality Liver Neoplasms - secondary Liver Neoplasms - therapy Liver, biliary tract, pancreas, portal circulation, spleen Liver. Biliary tract. Portal circulation. Exocrine pancreas Male Medical sciences Middle Aged Retrospective Studies Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases Surgery of the digestive system Survival Rate Tumors |
| title | Transcatheter Arterial Chemoembolization with or without Radiofrequency Ablation in the Management of Patients with Advanced Hepatic Malignancy |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-23T04%3A33%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Transcatheter%20Arterial%20Chemoembolization%20with%20or%20without%20Radiofrequency%20Ablation%20in%20the%20Management%20of%20Patients%20with%20Advanced%20Hepatic%20Malignancy&rft.jtitle=The%20American%20surgeon&rft.au=Bloomston,%20Mark&rft.date=2002-09-01&rft.volume=68&rft.issue=9&rft.spage=827&rft.epage=831&rft.pages=827-831&rft.issn=0003-1348&rft.eissn=1555-9823&rft.coden=AMSUAW&rft_id=info:doi/10.1177/000313480206800920&rft_dat=%3Cproquest_cross%3E72141464%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=212808452&rft_id=info:pmid/12356160&rft_sage_id=10.1177_000313480206800920&rfr_iscdi=true |